Synthesis and biological evaluation of 3,7-diazabicyclo[4.3.0]nonan-8-ones as potential nootropic and analgesic drugs.
暂无分享,去创建一个
C. Ghelardini | C. Bertucci | G. Bartolucci | S. Dei | E. Teodori | M. Romanelli | L. di Cesare Mannelli | L. Guandalini | D. Manetti | S. Scapecchi | E. Martini
[1] M. Prostran,et al. Analysis of the antinociceptive interactions in two-drug combinations of gabapentin, oxcarbazepine and amitriptyline in streptozotocin-induced diabetic mice. , 2010, European journal of pharmacology.
[2] I. Obrosova. Diabetic painful and insensate neuropathy: Pathogenesis and potential treatments , 2009, Neurotherapeutics.
[3] C. Albright,et al. Therapeutic Strategies for Alzheimer’s Disease , 2008, Molecular Neurobiology.
[4] S. Canpolat,et al. Antinociceptive efficacy of levetiracetam in a mice model for painful diabetic neuropathy , 2008, Acta anaesthesiologica Scandinavica.
[5] J. Levine,et al. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. , 2008, The journal of pain : official journal of the American Pain Society.
[6] T. Wilens,et al. Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. , 2007, Biochemical pharmacology.
[7] P. Panegyres,et al. Cognitive impairment in multiple sclerosis: Evidence-based analysis and recommendations , 2007, Journal of Clinical Neuroscience.
[8] J. Kennedy. Neuropathic pain: molecular complexity underlies continuing unmet medical need. , 2007, Journal of medicinal chemistry.
[9] P. Bottoni,et al. An update on pharmacological approaches to neurodegenerative diseases , 2007, Expert opinion on investigational drugs.
[10] Philip D. Harvey,et al. Treatment of cognitive deficits in schizophrenia. , 2006, Current opinion in investigational drugs.
[11] N. Callizot,et al. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy. , 2006, European journal of pharmacology.
[12] C. Ghelardini,et al. Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers. , 2006, CNS drug reviews.
[13] C. Ghelardini,et al. Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent. , 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).
[14] Y. Tanabe,et al. Ti‐Crossed‐Claisen Condensation Between Carboxylic Esters and Acid Chlorides or Acids: A Highly Selective and General Method for the Preparation of Various β‐Keto Esters. , 2005 .
[15] R. J. Cersosimo. Oxaliplatin-Associated Neuropathy: A Review , 2005, The Annals of pharmacotherapy.
[16] D. Alkon,et al. Emerging targets for the pharmacology of learning and memory. , 2004, Pharmacological research.
[17] C. Ghelardini,et al. Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs. , 2004, Bioorganic & medicinal chemistry.
[18] A. Pittaluga,et al. AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram) , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.
[19] C. Ghelardini,et al. 4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs. , 2003, Bioorganic & medicinal chemistry letters.
[20] P. Sirois,et al. Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice , 2003, Neuropeptides.
[21] H. Ueda,et al. Nonopioid and Neuropathy-Specific Analgesic Action of the Nootropic Drug Nefiracetam in Mice , 2002, Journal of Pharmacology and Experimental Therapeutics.
[22] M. Jarvik,et al. An Improved One-Trial Passive Avoidance Learning Situation , 1967, Psychological reports.
[23] T. Yano,et al. Mexiletine reverses oxaliplatin-induced neuropathic pain in rats. , 2010, Journal of pharmacological sciences.
[24] Maria Novella Romanelli,et al. Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs. , 2002, Current pharmaceutical design.
[25] Davidr . Evans,et al. Contrasteric carboximide hydrolysis with lithium hydroperoxide , 1987 .
[26] A. Malykh,et al. Piracetam and Piracetam-Like Drugs From Basic Science to Novel Clinical Applications to CNS Disorders , 2022 .